abstract |
The present invention relates to novel fatty acid analogous of the general formula (I): R1- [xi - CH2]n - COOR2, wherein R1, R2, Xi and n are defined in the description a salt, prodrug or complex thereof, which can be used for the treatment and/or prevention of syndrome X, obesity, hypertension, fatty liver, diabetes, hyperglycaemia, hyperinsulinemia and stenosis. Further, the invention relates to a nutritional composition comprising said fatty acid analogous, and a method for reducing the total weight, or the amount of adipose tissue in an animal. |